3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
310
Lung Neoplasms
71
Neoplasms
51
Neoplasm Metastasis
34
Colorectal Neoplasms
21
Carcinoma
21
Parkinson Disease 4, Autosomal Dominant Lewy Body
20
Mesothelioma
15
Breast Neoplasms
15
Mesothelioma, Malignant
13
Small Cell Lung Carcinoma
11
Neoplasms by Site
10
Melanoma
10
Adenocarcinoma
10
Pancreatic Neoplasms
8
Adenocarcinoma of Lung
8
Ovarian Neoplasms
7
Lung Diseases
7
Thoracic Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
6
Non-Squamous Non-Small Cell Lung Cancer
6
Uterine Cervical Neoplasms
5
Respiratory Tract Neoplasms
5
Respiratory Tract Diseases
5
Recurrence
5
Rectal Neoplasms
5
Neoplasms by Histologic Type
5
NSCLC
5
Head and Neck Neoplasms
5
Endometrial Neoplasms
5
Interventions
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Bronchial Diseases
×
Pemetrexed
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts